DK3324948T3 - Flerlagsmikropartikler til frigivelse af en farmaceutisk aktiv forbindelse i en flydende doseringsform - Google Patents
Flerlagsmikropartikler til frigivelse af en farmaceutisk aktiv forbindelse i en flydende doseringsform Download PDFInfo
- Publication number
- DK3324948T3 DK3324948T3 DK16738185.4T DK16738185T DK3324948T3 DK 3324948 T3 DK3324948 T3 DK 3324948T3 DK 16738185 T DK16738185 T DK 16738185T DK 3324948 T3 DK3324948 T3 DK 3324948T3
- Authority
- DK
- Denmark
- Prior art keywords
- release
- dosage form
- active compound
- pharmaceutically active
- liquid dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP15177221.7A EP3117824A1 (en) | 2015-07-17 | 2015-07-17 | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
BE20165555A BE1024339B1 (fr) | 2016-07-01 | 2016-07-01 | Microparticules multicouches libérant un composé pharmaceutiquement actif dans une forme pharmaceutique liquide |
PCT/EP2016/066597 WO2017012935A1 (en) | 2015-07-17 | 2016-07-13 | Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3324948T3 true DK3324948T3 (da) | 2023-05-08 |
Family
ID=56409108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK16738185.4T DK3324948T3 (da) | 2015-07-17 | 2016-07-13 | Flerlagsmikropartikler til frigivelse af en farmaceutisk aktiv forbindelse i en flydende doseringsform |
Country Status (17)
Country | Link |
---|---|
US (1) | US20190008787A1 (da) |
EP (1) | EP3324948B1 (da) |
JP (1) | JP6796132B2 (da) |
KR (1) | KR102633566B1 (da) |
CN (1) | CN108348475B (da) |
AU (1) | AU2016294734B2 (da) |
CA (1) | CA2992356C (da) |
DK (1) | DK3324948T3 (da) |
ES (1) | ES2944568T3 (da) |
FI (1) | FI3324948T3 (da) |
HR (1) | HRP20230250T1 (da) |
HU (1) | HUE061861T2 (da) |
LT (1) | LT3324948T (da) |
PL (1) | PL3324948T3 (da) |
RS (1) | RS64088B1 (da) |
SI (1) | SI3324948T1 (da) |
WO (1) | WO2017012935A1 (da) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107638333A (zh) * | 2017-09-29 | 2018-01-30 | 点铂医疗科技(常州)有限公司 | 一种茶多酚/壳聚糖微粒及其制备方法 |
GB201716716D0 (en) | 2017-10-12 | 2017-11-29 | Univ Of Hertfordshire Higher Education Corporation | Method for coating particles |
BR112020013398A2 (pt) * | 2018-01-03 | 2020-12-01 | Ferring B.V. | composições farmacêuticas líquidas orais de aminossalicilatos |
CN111789808A (zh) * | 2019-04-08 | 2020-10-20 | 生达化学制药股份有限公司 | 口服医药组成物及其结构 |
EP4072532B1 (en) * | 2019-12-11 | 2024-01-24 | Evonik Operations GmbH | Dosage form for use in treating or preventing of a disease |
US20220071913A1 (en) * | 2020-09-10 | 2022-03-10 | Sawai Pharmaceutical Co., Ltd. | Granule, preparation containing the granule, production method of the granule, and production method of preparation containing the granule |
KR20230071712A (ko) * | 2021-11-16 | 2023-05-23 | 오즈온바이오 주식회사 | 산 민감성 무기성분을 포함하는 삼투성 제제 조성물 |
CN115300506A (zh) * | 2022-08-11 | 2022-11-08 | 南京红地生物科技有限公司 | 含有坦索罗辛和米拉贝隆的复方制剂及其制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2189698A (en) * | 1986-04-30 | 1987-11-04 | Haessle Ab | Coated omeprazole tablets |
DK0419861T3 (da) * | 1989-08-29 | 1996-03-04 | Boehringer Ingelheim Pharma | Anvendelse af dibenz(b,f) (1,4)oxazepin (og thiazepin)-11(10H)-oner og -thioner til fremstilling af farmaceutisk præparat til forebyggelse eller behandling af AIDS |
FR2774288B1 (fr) | 1998-01-30 | 2001-09-07 | Ethypharm Sa | Microgranules d'omeprazole gastroproteges, procede d'obtention et preparations pharmaceutiques |
DK1146862T3 (da) | 1999-01-29 | 2003-07-21 | Disphar Int Bv | Farmaceutiske sammensætninger |
US20040006109A1 (en) | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of non-enterically coated acid-labile drugs |
US20040005362A1 (en) | 2002-07-03 | 2004-01-08 | Rajneesh Taneja | Liquid dosage forms of acid labile drugs |
CN1938026A (zh) | 2004-03-26 | 2007-03-28 | 卫材R&D管理有限公司 | 控释制剂及其制造方法 |
US20060134210A1 (en) | 2004-12-22 | 2006-06-22 | Astrazeneca Ab | Solid dosage form comprising proton pump inhibitor and suspension made thereof |
US20070098746A1 (en) * | 2005-11-02 | 2007-05-03 | Nichols William M | Multi-layered coating technology for taste masking |
WO2011107855A2 (en) * | 2010-03-04 | 2011-09-09 | Torrent Pharmaceuticals Limited | Sustained release oral liquid suspension dosage form |
DE102010052847A1 (de) * | 2010-11-29 | 2012-05-31 | Temmler Werke Gmbh | Verfahren zur Herstellung einer PPI-haltigen pharmazeutischen Zubereitung |
DK4011364T3 (da) * | 2011-03-23 | 2024-03-18 | Ironshore Pharmaceuticals & Dev Inc | Fremgangsmåder og sammensætninger til behandling af ADD (Attention Deficit Disorder) |
-
2016
- 2016-07-13 HR HRP20230250TT patent/HRP20230250T1/hr unknown
- 2016-07-13 DK DK16738185.4T patent/DK3324948T3/da active
- 2016-07-13 PL PL16738185.4T patent/PL3324948T3/pl unknown
- 2016-07-13 WO PCT/EP2016/066597 patent/WO2017012935A1/en unknown
- 2016-07-13 LT LTEPPCT/EP2016/066597T patent/LT3324948T/lt unknown
- 2016-07-13 FI FIEP16738185.4T patent/FI3324948T3/fi active
- 2016-07-13 KR KR1020187004004A patent/KR102633566B1/ko active IP Right Grant
- 2016-07-13 JP JP2018521698A patent/JP6796132B2/ja active Active
- 2016-07-13 RS RS20230244A patent/RS64088B1/sr unknown
- 2016-07-13 CN CN201680054102.9A patent/CN108348475B/zh active Active
- 2016-07-13 AU AU2016294734A patent/AU2016294734B2/en active Active
- 2016-07-13 CA CA2992356A patent/CA2992356C/en active Active
- 2016-07-13 US US15/745,190 patent/US20190008787A1/en active Pending
- 2016-07-13 ES ES16738185T patent/ES2944568T3/es active Active
- 2016-07-13 SI SI201631681T patent/SI3324948T1/sl unknown
- 2016-07-13 HU HUE16738185A patent/HUE061861T2/hu unknown
- 2016-07-13 EP EP16738185.4A patent/EP3324948B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
HRP20230250T1 (hr) | 2023-04-14 |
HUE061861T2 (hu) | 2023-08-28 |
JP2018521137A (ja) | 2018-08-02 |
EP3324948B1 (en) | 2023-02-15 |
CA2992356A1 (en) | 2017-01-26 |
WO2017012935A1 (en) | 2017-01-26 |
AU2016294734A1 (en) | 2018-02-01 |
US20190008787A1 (en) | 2019-01-10 |
RS64088B1 (sr) | 2023-04-28 |
SI3324948T1 (sl) | 2023-05-31 |
LT3324948T (lt) | 2023-03-27 |
ES2944568T3 (es) | 2023-06-22 |
CN108348475B (zh) | 2022-01-04 |
CA2992356C (en) | 2024-02-13 |
PL3324948T3 (pl) | 2023-06-26 |
JP6796132B2 (ja) | 2020-12-02 |
KR102633566B1 (ko) | 2024-02-05 |
CN108348475A (zh) | 2018-07-31 |
EP3324948A1 (en) | 2018-05-30 |
AU2016294734B2 (en) | 2021-01-28 |
FI3324948T3 (fi) | 2023-05-05 |
KR20180042853A (ko) | 2018-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL301217I2 (nl) | tirzepatide en farmaceutisch aanvaardbare zouten daarvan | |
NO2022046I1 (no) | Berotralstat and pharmaceutically acceptable salts thereof | |
DK3324948T3 (da) | Flerlagsmikropartikler til frigivelse af en farmaceutisk aktiv forbindelse i en flydende doseringsform | |
DK3236943T3 (da) | Sammensætninger til ileo-jejunal lægemiddeladministration | |
DK3030227T3 (da) | Vedvarende frigivelses-doseringsformer for en jak1-inhibitor | |
DK3419700T3 (da) | Indretning til dosiskontrol af indretning til afgivelse af injicerbar lægemiddel | |
DK3265421T3 (da) | Doseringssystem | |
DK3310414T3 (da) | Lægemiddeladministrationsanordning | |
DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
DK3099356T3 (da) | Medikamentadministrationsanordning | |
DK3529240T3 (da) | Farmaceutiske forbindelser | |
IL259273A (en) | Porous structures for sustained release drug delivery devices | |
DK3261951T3 (da) | Pakkestruktur til beholdere til farmaceutisk anvendelse | |
DK3380146T3 (da) | Medikamentadministrationsanordning | |
DK3380139T3 (da) | Medikamentadministrationsanordning | |
DK3071268T3 (da) | Indretning til en lægemiddeladministrationsanordning | |
DK3145488T3 (da) | Flydende farmaceutiske forbindelse | |
DK3021911T3 (da) | Anordning til indgivelse af lægemidler | |
DK2968780T3 (da) | Indretning til en lægemiddeladministrationsanordning | |
DK3349825T3 (da) | Lægemiddeladministrationsanordning | |
DK3286190T3 (da) | Farmaceutiske saltformer af en inhibitor af semicarbazid-sensitiv aminoxidase (ssao) | |
DK3204090T3 (da) | Nulstillelig anordning til indgivelse af lægemidler | |
DK3148618T3 (da) | Lægemiddeladministrationsanordning til administration af to medikamenter | |
DK3079667T3 (da) | Farmaceutiske doseringsformer |